Symbol="ARDX"
AssetType="Common Stock"
Name="Ardelyx Inc"
Description="Ardelyx, Inc., a biopharmaceutical company, develops and sells drugs for the treatment of kidney and cardiorenal diseases in the United States and internationally. The company is headquartered in Fremont, California."
CIK="1437402"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="34175 ARDENWOOD BLVD., FREMONT, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="931364000"
EBITDA="-45180000"
PERatio="None"
PEGRatio="-0.08"
BookValue="0.565"
DividendPerShare="0"
DividendYield="0"
EPS="-0.23"
RevenuePerShareTTM="0.425"
ProfitMargin="-0.677"
OperatingMarginTTM="-0.558"
ReturnOnAssetsTTM="-0.169"
ReturnOnEquityTTM="-0.637"
RevenueTTM="82866000"
GrossProfitTTM="15540000"
DilutedEPSTTM="-0.23"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="7.84"
AnalystTargetPrice="9.36"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="39.54"
PriceToBookRatio="5.52"
EVToRevenue="35.06"
EVToEBITDA="-2.879"
Beta="1.176"
num_52WeekHigh="5.12"
num_52WeekLow="0.98"
num_50DayMovingAverage="3.66"
num_200DayMovingAverage="3.415"
SharesOutstanding="214462000"
DividendDate="None"
ExDividendDate="None"
symbol="ARDX"
open="4.27"
high="4.29"
low="4.18"
price="4.26"
volume="4916385.00"
latest_trading_day="2023-08-31"
previous_close="4.24"
change="0.02"
change_percent="0.4717%"
aroon_positive_momentum_days="48"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="48"
Volume_recent_avg="5005597"
Change_recent_avg="-0.01"
Delta_recent_avg="0.22"
Variance_recent_avg="0.11"
Change_ratio_recent_avg="-0.23"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="48"
Aroon_momentum_negative="52"
image_negative_thumbnail_id_1="1146"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0179.jpeg"
image_negative_thumbnail_id_2="1100"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0133.jpeg"
image_neutral_thumbnail_id_1="531"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0068.jpeg"
image_neutral_thumbnail_id_2="565"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0034.jpeg"
image_positive_thumbnail_id_1="975"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0137.jpeg"
image_positive_thumbnail_id_2="960"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0122.jpeg"
image_professor_thumbnail_id_1="1184"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
image_professor_thumbnail_id_2="1172"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
